Guardant Health
$149.459876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$149.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$12.79 (-7.88%) Today
$0.00 (0.00%) As of 1:21 PM UTC after-hours
Why Robinhood?
You can buy or sell GH and other stocks, options, and ETFs commission-free!
About GH
Guardant Health, Inc. Common Stock, also called Guardant Health, is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Redwood City, CA. The listed name for GH is Guardant Health, Inc. Common Stock.
CEO
Helmy Eltoukhy
Employees
622
Headquarters
Redwood City, California
Founded
2012
Market Cap
14.75B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.17M
High Today
$154.90
Low Today
$146.00
Open Price
$153.00
Volume
2.99M
52 Week High
$181.07
52 Week Low
$55.90
Analyst Ratings
92%
of 12 ratings
Buy
92%
Hold
0%
Sell
8%
GH Earnings
-$0.94
-$0.67
-$0.40
-$0.13
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.57 per share
Actual
-$0.94 per share